Valneva's technology platforms complement its product pipeline.

The strengths of the Company's technologies are validated by partnerships and collaborations with world leading research-based pharmaceutical and healthcare companies.

Valneva has two proprietary technology platforms: the EB66® cell line and the IC31® adjuvant.

 

Please update your browser...